神经重症监护病房神经功能完好患者及其非正式照护者基线创伤后应激障碍症状严重程度、特定症状与3个月生活质量的相关性
该先导性研究于2015至2016年纳入神经功能完好的神经重症监护病房患者70例及非正式照护者64例,在住院期间用PTSD检查表特定版(PCL-S)评估创伤后应激障碍症状,3个月后用世界卫生组织生活质量简表(WHOQOL-BREF)评估生活质量。结果显示,患者与照护者创伤后应激障碍症状各维度间呈中度至强相关(患者r=0.65-0.79,照护者r=0.55-0.78,均p<0.001);校正临床重要变量后,症状总评分越高,3个月各领域生活质量越低(β=-0.289至-0.622,p<0.05)。探索性分析提示,麻木症状与患者心理领域生活质量较低相关,与照护者躯体、心理及社会领域生活质量较低相关;再体验症状与患者及照护者躯体领域生活质量较低相关。作者认为这些初步结果提示神经重症监护病房住院期间的患者及照护者创伤后应激障碍症状可预测3个月生活质量,仍需继续研究以确定该人群创伤后应激障碍与生活质量的干预靶点。
要点
- 神经重症监护病房神经功能完好患者70例与照护者64例中,住院期间创伤后应激障碍症状总评分越高,3个月各领域生活质量越低(β=-0.289至-0.622,p<0.05)。
- 照护者麻木症状越重,3个月躯体(β=-0.409,p=0.014)、心理(β=-0.519,p=0.001)及社会(β=-0.704,p<0.001)领域生活质量越低。
- 患者麻木症状越重,3个月心理领域生活质量越低(β=-0.397,p=0.038);再体验症状越重,患者(β=-0.422,p=0.047)与照护者(β=-0.4,p=0.041)躯体领域生活质量越低。
- 患者创伤后应激障碍症状各维度间r=0.65-0.79(p<0.001),照护者各维度间r=0.55-0.78(p<0.001),提示症状维度间高度共变。
- 作者认为神经重症监护病房住院期间患者及照护者的创伤后应激障碍症状可预测3个月生活质量,仍需继续研究以确定干预靶点。
适用人群与场景
- 神经重症监护病房中神经功能完好的患者(70例,45.7%女性,84.3%白人,平均年龄52.08岁)及其非正式照护者(64例,64.1%女性,90.6%白人,平均年龄53.12岁)。
- 患者于神经重症监护病房住院期间入组并提供人口学资料与创伤后应激障碍症状评估,3个月后完成生活质量评估。
研究设计与关键结果
- 先导性研究,2015至2016年纳入神经功能完好的神经重症监护病房患者70例及非正式照护者64例;住院期间用PTSD检查表特定版(PCL-S)评估创伤后应激障碍症状,3个月后用世界卫生组织生活质量简表(WHOQOL-BREF)评估躯体、心理、社会及环境四个领域生活质量。
- 患者创伤后应激障碍症状各维度间r=0.65-0.79(p<0.001),照护者各维度间r=0.55-0.78(p<0.001)。
- 校正临床重要变量后,患者与照护者创伤后应激障碍症状总评分越高,3个月各领域生活质量越低(β=-0.289至-0.622,p<0.05)。
- 校正性别与年龄的探索性分析显示,患者麻木症状越重心理领域生活质量越低(β=-0.397,p=0.038);照护者麻木症状越重躯体(β=-0.409,p=0.014)、心理(β=-0.519,p=0.001)及社会(β=-0.704,p<0.001)领域生活质量越低。
- 再体验症状越重,患者躯体领域生活质量越低(β=-0.422,p=0.047),照护者躯体领域生活质量越低(β=-0.4,p=0.041)。
证据类型、等级与局限
- 证据类型:先导性研究(摘要未报告具体研究设计类型)。
- 作者结论指出结果为初步结果,仍需继续研究以确定该人群创伤后应激障碍与生活质量的干预靶点。
- 局限:原文未报告局限性。
对床旁实践的改变
- 作者认为神经重症监护病房住院期间患者及照护者创伤后应激障碍症状(尤其麻木与再体验症状)可预测3个月较差生活质量,仍需继续研究以确定干预靶点。
提炼说明
- 本条依据论文摘要整理;摘要未涉及「诊断标准与关键阈值」「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开
BACKGROUND: The objective is to pilot test the feasibility of assessing severity of posttraumatic stress disorder (PTSD) symptoms, as well as specific lower-order PTSD symptoms, experienced during neurological intensive care unit (neuro-ICU) admission and their relationship with 3-month quality of life (QoL) scores in multiple domains (i.e., physical, psychological, social, and environmental) in both patients and caregivers.
METHODS: Between 2015 and 2016, we enrolled neurologically intact patients and informal caregivers of patients who reported demographics and PTSD symptoms (PTSD Checklist-Specific; PCL-S) during neuro-ICU admission and completed a QoL assessment (World Health Organization Quality of Life; WHOQOL-BREF) 3 months later. Clinical data were extracted from medical records. We ran two bivariate correlation matrices among PTSD symptom dimensions in patients and caregivers. Then, we used multiple linear regression to examine the prospective association of total PCL-S scores with each QoL domain in both patients and caregivers after adjusting for clinically important variables. Next, we explored differential associations between the 4 PTSD symptom dimensions and each QoL domain in both patients and caregivers, adjusting for sex and age.
RESULTS: A total of 70 patients (45.7% women, 84.3% white, mean age 52.08 years) and 64 caregivers (64.1% women, 90.6% white, mean age 53.12 years) were included. PTSD symptom dimensions were moderately strongly correlated among patients (r = 0.65-0.79, p < 0.001) and caregivers (r = 0.55-0.78, p < 0.001). For both patients and caregivers, greater PTSD symptom severity was prospectively associated with lower QoL in all domains (β = - 0.289 to - 0.622; p < 0.05). Our exploratory analysis revealed that greater numbing symptoms were associated with lower psychological QoL in patients (β: - 0.397, p = 0.038), and lower physical (β: - 0.409, p = 0.014), psychological (β: - 0.519, p = 0.001), and social QoL (β: - 0.704, p < 0.001) in caregivers. Greater re-experiencing symptoms were associated with lower physical QoL in both patients (β: - 0.422, p = 0.047) and caregivers (β: - 0.4, p = 0.041).
CONCLUSIONS: Our preliminary results indicated that greater severity of PTSD symptoms, and specifically numbing and re-experiencing symptoms, experienced by patients and caregivers during neuro-ICU admission was predictive of worse 3-month QoL. Continued study is needed to identify treatment targets for PTSD and QoL in this population.
参考来源
- Presciutti A, Meyers EE, Reichman M, et al. Associations Between Baseline Total PTSD Symptom Severity, Specific PTSD Symptoms, and 3-Month Quality of Life in Neurologically Intact Neurocritical Care Patients and Informal Caregivers. Neurocrit Care. 2021. PMID: 32356141. doi:10.1007/s12028-020-00980-w
供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。